Cytokinetics, Incorporated Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.4M | 17.8M | 1.9M | 66.8M | 1.6M | 16.9M | 463K | 249K |
| Cost of Goods Sold | 2.4M | 2.9M | 2.7M | 2.3M | 99.8M | 93.6M | 84.6M | 79.6M |
| Gross Profit | 17.0M | 14.9M | -743K | 64.5M | -98.3M | -76.7M | -84.1M | -79.3M |
| R&D Expenses | 95.5M | 101.5M | 99.2M | 112.6M | 99.8M | 93.6M | 84.6M | 79.6M |
| Operating Expenses | 200.6M | 193.3M | 166.0M | 176.0M | 57.4M | 62.3M | 56.7M | 50.8M |
| Operating Income | -183.6M | -178.4M | -166.8M | -111.5M | -155.6M | -139.0M | -140.8M | -130.2M |
| Other Income / Gains | -22.4M | -4.7M | -139.4M | -22.9M | -5.7M | -11.0M | -19.7M | -13.1M |
| Net Income | -206.0M | -183.0M | -306.2M | -134.4M | -161.4M | -150.0M | -160.5M | -143.3M |
| EPS (Diluted) | -1.67 | -1.49 | -2.55 | -1.12 | -1.36 | -1.27 | -1.36 | -1.31 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.876 | 0.839 | -0.384 | 0.966 | -62.231 | -4.531 | -181.747 | -318.667 |
| General And Administrative Expenses | 0 | 91.7M | 69.5M | 65.7M | 57.4M | 62.3M | 56.7M | 50.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 104.9M | 91.7M | 69.5M | 65.7M | 57.4M | 62.3M | 56.7M | 50.8M |
| Other Expenses | 160K | 0 | -2.7M | -2.3M | -99.8M | -93.6M | -84.6M | -79.6M |
| Cost And Expenses | 203.0M | 196.1M | 168.7M | 178.3M | 157.2M | 156.0M | 141.3M | 130.4M |
| Interest Income | 11.0M | 11.5M | 10.2M | 13.0M | 13.7M | 15.0M | 17.1M | 11.6M |
| Interest Expense | 33.3M | 30.3M | 26.3M | 24.3M | 22.9M | 22.6M | 22.3M | 24.3M |
| Depreciation And Amortization | 3.4M | 2.7M | 2.7M | 2.3M | 2.3M | 2.4M | 2.4M | 2.4M |
| Ebitda | -180.2M | -180.4M | -277.2M | -107.8M | -136.1M | -125.0M | -135.8M | -116.6M |
| Ebitdaratio | -9.312 | -10.158 | -143.17 | -1.615 | -86.213 | -7.387 | -293.382 | -468.325 |
| Operating Income Ratio | -9.487 | -10.046 | -86.134 | -1.67 | -98.563 | -8.214 | -304.106 | -522.779 |
| Income Before Tax | -206.0M | -183.0M | -306.2M | -134.4M | -161.4M | -150.0M | -160.5M | -143.3M |
| Income Before Tax Ratio | -10.645 | -10.309 | -158.15 | -2.012 | -102.201 | -8.863 | -346.749 | -575.574 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -10.645 | -10.309 | -158.15 | -2.012 | -102.201 | -8.863 | -346.749 | -575.574 |
| Epsdiluted | -1.67 | -1.50 | -2.55 | -1.12 | -1.36 | -1.27 | -1.36 | -1.31 |
| Weighted Average Shs Out | 123.3M | 122.0M | 120.0M | 119.5M | 118.5M | 118.1M | 117.7M | 109.2M |
| Weighted Average Shs Out Dil | 123.3M | 122.4M | 120.0M | 119.5M | 118.5M | 118.1M | 117.7M | 109.2M |